ILIAS Biologics ILIAS Therapeutics

(주)셀렉스라이프사이언스

About us

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

MISSION“A new step to jump
toward a global
pharmaceutical
company”

In January 2019, ILIAS Therapeutics, Inc.
was established as wholly owned subsidary of ILIAS Biologics Inc.

ILIAS Therapeutics is expanding to develop novel exosome-based
therapeutics in the global market. To be a global pharmaceutical
company, we will collaborate with various research institutions and
build a sustainable business management system in the U.S.

Overview

  • Company name

    ILIAS Therapeutics, Inc.

  • CEO

    Jamie Kim, MS

  • Chairman of the board

    Chulhee Choi MD, PhD

  • Founded

    January 22, 2019

Contact Us

  • Contact emailjamiekim@iliasbio.com

  • TEL(+1) 917-747-0776

Overview

Mission

Contact Us

TOP

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기